Education and Training

Awards and Honors

• Honorary Doctorate in Medicine, Lund University, Sweden, 2015.
• Fellow, AAPM, 2016.

Publications

1. Meyer C, Stuparu A, Lueckerath K, Calais J, Czernin J, Slavik R, Dahlbom M. Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023.
2. Mellhammar E, Dahlbom M, Vilhelmsson-Timmermand O, Strand SE. Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023.
3. Ma TM, Czernin J, Felix C, Alano R, Wilhalme H, Valle L, Steinberg ML, Dahlbom M, Reiter RE, Rettig MB, Cao M, Calais J, Kishan AU. LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).. BJU international, 2023.
4. Hope TA, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald LK, Graham MM, Jacene HA, Heath CL, Mittra ES, Wright CL, Fendler WP, Herrmann K, Taïeb D, Kjaer A. SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023.
5. Colbert CM, Hollowed JJ, Nguyen DN, Duarte-Vogel S, Dahlbom M, Hu P, Nguyen KL. Fractional myocardial blood volume by ferumoxytol-enhanced MRI: Estimation of ischemic burden.. Magnetic resonance in medicine, 2022.
6. Meyer C, Prasad V, Stuparu A, Kletting P, Glatting G, Miksch J, Solbach C, Lueckerath K, Nyiranshuti L, Zhu S, Czernin J, Beer AJ, Slavik R, Calais J, Dahlbom M. Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225.. EJNMMI research, 2022.
7. Mellhammar E, Dahlbom M, Vilhelmsson-Timmermand O, Strand SE. Small-scale dosimetry for alpha particle 241Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3.. EJNMMI physics, 2022.
8. Calais J, Czernin J, Thin P, Gartmann J, Nguyen K, Armstrong WR, Allen-Auerbach M, Quon A, Bahri S, Gupta P, Gardner L, Dahlbom M, He B, Esfandiari R, Ranganathan D, Herrmann K, Eiber M, Fendler WP, Delpassand E. Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312).. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021.
9. Calais J, Gafita A, Eiber M, Armstrong WR, Gartmann J, Thin P, Nguyen K, Lok V, Gosa L, Grogan T, Esfandiari R, Allen-Auerbach M, Quon A, Bahri S, Gupta P, Gardner L, Ranganathan D, Slavik R, Dahlbom M, Herrmann K, Delpassand E, Fendler WP, Czernin J. Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021.
10. Nagy F, Krizsan AK, Kukuts K, Szolikova M, Hascsi Z, Barna S, Acs A, Szabo P, Tron L, Balkay L, Dahlbom M, Zentai M, Forgacs A, Garai I. Q-Bot: automatic DICOM metadata monitoring for the next level of quality management in nuclear medicine.. EJNMMI physics, 2021.
11. Armstrong WR, Gafita A, Zhu S, Thin P, Nguyen K, Alano R, Lira S, Booker K, Gardner L, Grogan T, Elashoff D, Allen-Auerbach M, Dahlbom M, Czernin J, Calais J. The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021.
12. Stuparu AD, Capri JR, Meyer CAL, Le TM, Evans-Axelsson SL, Current K, Lennox M, Mona CE, Fendler WP, Calais J, Eiber M, Dahlbom M, Czernin J, Radu CG, Lückerath K, Slavik R. Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020.
13. Urbán S, Meyer C, Dahlbom M, Farkas I, Sipka G, Besenyi Z, Czernin J, Calais J, Pávics L. Radiation Dosimetry of 99mTc-PSMA I&S: A Single-Center Prospective Study.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020.
14. Tsai WK, Zettlitz KA, Dahlbom M, Reiter RE, Wu AM. Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer.. Molecular imaging and biology, 2020.
15. Stuparu AD, Meyer CAL, Evans-Axelsson SL, Lückerath K, Wei LH, Kim W, Poddar S, Mona CE, Dahlbom M, Girgis MD, Radu CG, Czernin J, Slavik R. Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study.. Theranostics, 2020.
16. Meyer C, Dahlbom M, Lindner T, Vauclin S, Mona C, Slavik R, Czernin J, Haberkorn U, Calais J. Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019.
17. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.. The Lancet. Oncology, 2019.
18. Forgacs A, Kallos-Balogh P, Nagy F, Krizsan AK, Garai I, Tron L, Dahlbom M, Balkay L. Activity painting: PET images of freely defined activity distributions applying a novel phantom technique.. PloS one, 2019.
19. Maddahi J, Bengel F, Czernin J, Crane P, Dahlbom M, Schelbert H, Sparks R, Phelps M, Lazewatsky J. Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging.. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018.
20. Mellhammar E, Dahlbom M, Evans-Axelsson S, Strand SE. Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018.
21. Schelbert HR, Dahlbom M. A good beginning with an uncertain future.. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017.
22. Torosyan N, Mason K, Dahlbom M, Silverman DHS, Alzheimer’sDisease Neuroimaging Initiative. Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline.. European journal of nuclear medicine and molecular imaging, 2017.
23. Forgacs A, Pall Jonsson H, Dahlbom M, Daver F, D DiFranco M, Opposits G, K Krizsan A, Garai I, Czernin J, Varga J, Tron L, Balkay L. A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images.. PloS one, 2016.
24. Mellhammar E, Dahlbom M, Axelsson J, Strand SE. Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016.
25. Krizsan AK, Lajtos I, Dahlbom M, Daver F, Emri M, Kis SA, Opposits G, Pohubi L, Potari N, Hegyesi G, Kalinka G, Gal J, Imrek J, Nagy F, Valastyan I, Kiraly B, Molnar J, Sanfilippo D, Balkay L. A Promising Future: Comparable Imaging Capability of MRI-Compatible Silicon Photomultiplier and Conventional Photosensor Preclinical PET Systems.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015.
26. Örbom A, Ahlstedt J, Serén T, Auterinen I, Kotiluoto P, Hauge H, Östlund K, Olafsen T, Wu AM, Dahlbom M, Strand SE. Characterization of a double-sided silicon strip detector autoradiography system.. Medical physics, 2015.
27. Poon JK, Dahlbom ML, Casey ME, Qi J, Cherry SR, Badawi RD. Validation of the SimSET simulation package for modeling the Siemens Biograph mCT PET scanner.. Physics in medicine and biology, 2015.
28. Jani SS, Lamb JM, White BM, Dahlbom M, Robinson CG, Low DA. Assessing margin expansions of internal target volumes in 3D and 4D PET: a phantom study.. Annals of nuclear medicine, 2014.
29. Ye H, Wong KP, Wardak M, Dahlbom M, Kepe V, Barrio JR, Nelson LD, Small GW, Huang SC. Automated movement correction for dynamic PET/CT images: evaluation with phantom and patient data.. PloS one, 2014.
30. Packard RR, Huang SC, Dahlbom M, Czernin J, Maddahi J. Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014.
31. Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, Vera DR, Balkay L. Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom.. Physics in medicine and biology, 2014.
32. Wardak M, Schiepers C, Cloughesy TF, Dahlbom M, Phelps ME, Huang SC. ¹⁸F-FLT    and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.. European journal of nuclear medicine and molecular imaging, 2014.
33. Bai B, Lin Y, Zhu W, Ren R, Li Q, Dahlbom M, DiFilippo F, Leahy RM. MAP reconstruction for Fourier rebinned TOF-PET data.. Physics in medicine and biology, 2014.
34. Jani SS, Robinson CG, Dahlbom M, White BM, Thomas DH, Gaudio S, Low DA, Lamb JM. A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.. International journal of radiation oncology, biology, physics, 2013.
35. Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J. Evaluation of the Genisys4, a bench-top preclinical PET scanner.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013.
36. Zhang X, Schindler TH, Prior JO, Sayre J, Dahlbom M, Huang SC, Schelbert HR. Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy.. European journal of nuclear medicine and molecular imaging, 2013.
37. Schiepers C, Huang SC, Dahlbom M. Dynamic PET/CT with 11C-acetate in prostate cancer.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012.
38. Poon JK, Dahlbom ML, Moses WW, Balakrishnan K, Wang W, Cherry SR, Badawi RD. Optimal whole-body PET scanner configurations for different volumes of LSO scintillator: a simulation study.. Physics in medicine and biology, 2012.
39. Dahlbom M, Kriszan A, Czernin J. SU-E-I-82: Image Signal-To-Noise Equalization in Whole Body PET Using Variable Acquisition Times.. Medical physics, 2012.
40. Lamb J, Lee P, Jani S, Dahlbom M, White B, Low D. SU-E-J-169: 4D-PET for Abdominal Tumor Target Volume Generation.. Medical physics, 2012.
41. Dahlbom M, Mawlawi O. TU-E-218-01: PET/CT QA/QC and Acceptance Testing.. Medical physics, 2012.
42. Jani S, Lamb J, Dahlbom M, Robinson C, White B, Low D. WE-G-213CD-02: 4D-PET Maximum Intensity Projections Improve Accuracy of Mobile Tumor Volume Delineation.. Medical physics, 2012.
43. Wong KP, Kepe V, Dahlbom M, Satyamurthy N, Small GW, Barrio JR, Huang SC. Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.. NeuroImage, 2011.
44. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Geist C, Dahlbom M, Silverman DH, Satyamurthy N, Phelps ME, Chen W. 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011.
45. Wardak M, Schiepers C, Dahlbom M, Cloughesy T, Chen W, Satyamurthy N, Czernin J, Phelps ME, Huang SC. Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011.
46. Maddahi J, Czernin J, Lazewatsky J, Huang SC, Dahlbom M, Schelbert H, Sparks R, Ehlgen A, Crane P, Zhu Q, Devine M, Phelps M. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011.
47. Groman SM, Lee B, London ED, Mandelkern MA, James AS, Feiler K, Rivera R, Dahlbom M, Sossi V, Vandervoort E, Jentsch JD. Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011.
48. Schiepers C, Dahlbom M. Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.. European radiology, 2010.
49. Schiepers C, Dahlbom M, Chen W, Cloughesy T, Czernin J, Phelps ME, Huang SC. Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010.
50. Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, Small GW, Barrio JR, Huang SC. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010.
51. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009.
52. Wong KP, Wardak M, Shao W, Dahlbom M, Kepe V, Liu J, Satyamurthy N, Small GW, Barrio JR, Huang SC. Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.. European journal of nuclear medicine and molecular imaging, 2009.
53. Heckathorne E, Dimock C, Dahlbom M. Radiation dose to surgical staff from positron-emitter-based localization and radiosurgery of tumors.. Health physics, 2008.
54. Schiepers C, Hoh CK, Nuyts J, Seltzer M, Wu C, Huang SC, Dahlbom M. 1-11C-acetate kinetics of prostate cancer.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008.
55. Schiepers C, Chen W, Cloughesy T, Dahlbom M, Huang SC. 18F-FDOPA kinetics in brain tumors.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007.
56. Schindler TH, Zhang XL, Vincenti G, Mhiri L, Nkoulou R, Just H, Ratib O, Mach F, Dahlbom M, Schelbert HR. Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction.. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2007.
57. Lin TW, de Aburto MA, Dahlbom M, Huang LL, Marvi MM, Tang M, Czernin J, Phelps ME, Silverman DH. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007.
58. Schindler TH, Zhang XL, Prior JO, Cadenas J, Dahlbom M, Sayre J, Schelbert HR. Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET.. European journal of nuclear medicine and molecular imaging, 2007.
59. Schiepers C, Chen W, Dahlbom M, Cloughesy T, Hoh CK, Huang SC. 18F-fluorothymidine kinetics of malignant brain tumors.. European journal of nuclear medicine and molecular imaging, 2007.
60. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C. Accuracy of PET/CT in characterization of solitary pulmonary lesions.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007.
61. Prior JO, Schindler TH, Facta AD, Hernandez-Pampaloni M, Campisi R, Dahlbom M, Schelbert HR. Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans.. European journal of nuclear medicine and molecular imaging, 2006.
62. Kesner AL, Dahlbom M, Huang SC, Hsueh WA, Pio BS, Czernin J, Kreissl M, Wu HM, Silverman DH. Semiautomated analysis of small-animal PET data.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006.
63. Schindler TH, Facta AD, Prior JO, Campisi R, Inubushi M, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Schelbert HR. PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction.. European journal of nuclear medicine and molecular imaging, 2006.
64. Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Licinio J, Schelbert HR. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function.. Journal of the American College of Cardiology, 2006.
65. Badawi RD, Dahlbom M. NEC: some coincidences are more equivalent than others.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005.
66. Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, Silverman DH, Ratib O, Czernin J. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005.
67. Solberg TD, Agazaryan N, Goss BW, Dahlbom M, Lee SP. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy.. Journal of neurosurgery, 2004.
68. Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlbom M, Phelps ME, Barrio JR. Radiation dose estimates in humans for (11)C-acetate whole-body PET.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004.
69. Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004.
70. Halpern BS, Dahlbom M, Waldherr C, Yap CS, Schiepers C, Silverman DH, Ratib O, Czernin J. Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004.
71. Inubushi M, Jordan MC, Roos KP, Ross RS, Chatziioannou AF, Stout DB, Dahlbom M, Schelbert HR. Nitrogen-13 ammonia cardiac positron emission tomography in mice: effects of clonidine-induced changes in cardiac work on myocardial perfusion.. European journal of nuclear medicine and molecular imaging, 2003.
72. Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003.
73. Strul D, Slates RB, Dahlbom M, Cherry SR, Marsden PK. An improved analytical detector response function model for multilayer small-diameter PET scanners.. Physics in medicine and biology, 2003.
74. Kudo T, Fukuchi K, Annala AJ, Chatziioannou AF, Allada V, Dahlbom M, Tai YC, Inubushi M, Huang SC, Cherry SR, Phelps ME, Schelbert HR. Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph.. Circulation, 2002.
75. Yaghoubi S, Barrio JR, Dahlbom M, Iyer M, Namavari M, Satyamurthy N, Goldman R, Herschman HR, Phelps ME, Gambhir SS. Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001.
76. Badawi RD, Ferreira NC, Kohlmyer SG, Dahlbom M, Marsden PK, Lewellen TK. A comparison of normalization effects on three whole-body cylindrical 3D PET systems.. Physics in medicine and biology, 2000.
77. Schelbert HR, Hoh CK, Royal HD, Brown M, Dahlbom MN, Dehdashti F, Wahl RL. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998.
78. Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, Hawkin RA, Maddahi J, Phelps ME. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997.
79. Hademenos GJ, Dahlbom M, Hoffman EJ. Simultaneous dual-isotope technetium-99m/thallium-201 cardiac SPET imaging using a projection-dependent spilldown correction factor.. European journal of nuclear medicine, 1995.
80. Ingvar M, Eriksson L, Greitz T, Stone-Elander S, Dahlbom M, Rosenqvist G, af Trampe P, von Euler C. Methodological aspects of brain activation studies: cerebral blood flow determined with [15O]butanol and positron emission tomography.. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1994.
81. Hoh CK, Dahlbom M, Hawkins RA, Glaspy JA, Yao WJ, Lee SJ, Maddahi J, Phelps ME. Basic principles of positron emission tomography in oncology: quantitation and whole body techniques.. Wiener klinische Wochenschrift, 1994.
82. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, Heiss WD. The ECAT EXACT HR: performance of a new high resolution positron scanner.. Journal of computer assisted tomography, 1994.
83. Hoh CK, Dahlbom M, Harris G, Choi Y, Hawkins RA, Phelps ME, Maddahi J. Automated iterative three-dimensional registration of positron emission tomography images.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993.
84. Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, Schiepers C, Choi Y, Rege S, Nitzsche E. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.. Journal of computer assisted tomography, 1993.
85. Rege SD, Hoh CK, Glaspy JA, Aberle DR, Dahlbom M, Razavi MK, Phelps ME, Hawkins RA. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.. Cancer, 1993.
86. Choi Y, Huang SC, Hawkins RA, Kuhle WG, Dahlbom M, Hoh CK, Czernin J, Phelps ME, Schelbert HR. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993.
87. Meikle SR, Dahlbom M, Cherry SR. Attenuation correction using count-limited transmission data in positron emission tomography.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993.
88. Hoh CK, Hawkins RA, Dahlbom M, Glaspy JA, Seeger LL, Choi Y, Schiepers CW, Huang SC, Satyamurthy N, Barrio JR. Whole body skeletal imaging with [18F]fluoride ion and PET.. Journal of computer assisted tomography, 1993.
89. Hawkins RA, Hoh C, Glaspy J, Choi Y, Dahlbom M, Rege S, Messa C, Nietszche E, Hoffman E, Seeger L. The role of positron emission tomography in oncology and other whole-body applications.. Seminars in nuclear medicine, 1992.